Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jun 9;4(6):1269-80.
doi: 10.3390/jcm4061269.

Kidney Transplantation in the Diabetic Patient

María José Pérez-Sáez  1 , Julio Pascual  2
Affiliations
Review

Kidney Transplantation in the Diabetic Patient

María José Pérez-Sáez et al. J Clin Med. .

Abstract

Diabetes mellitus is one of the most important causes of chronic kidney disease (CKD). In patients with advanced diabetic kidney disease, kidney transplantation (KT) with or without a pancreas transplant is the treatment of choice. We aimed to review current data regarding kidney and pancreas transplant options in patients with both type 1 and 2 diabetes and the outcomes of different treatment modalities. In general, pancreas transplantation is associated with long-term survival advantages despite an increased short-term morbidity and mortality risk. This applies to simultaneous pancreas kidney transplantation or pancreas after KT compared to KT alone (either living donor or deceased). Other factors as living donor availability, comorbidities, and expected waiting time have to be considered whens electing one transplant modality, rather than a clear benefit in survival of one strategy vs. others. In selected type 2 diabetic patients, data support cautious utilization of simultaneous pancreas kidney transplantation when a living kidney donor is not an option. Pancreas and kidney transplantation seems to be the treatment of choice for most type 1 diabetic and selected type 2 diabetic patients.

Keywords: diabetes; kidney transplantation; survival.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Diabetic patient treatment management proposed algorithm. eGFR, estimated glomerular filtration rate; LDKT, living donor kidney transplant; DDKT, deceased donor kidney transplant; SPK, simultaneous pancreas-kidney; PAK, pancreas after kidney; HD, hemodialysis; PD, peritoneal dialysis; ESRD, end-stage renal disease.
See this image and copyright information in PMC

References

    1. United States Renal Data System The 2014 Annual Date Report. Chapter 1: Incidence, prevalence, patient characteristics, and treatment modalities. [(accessed on 6 June 2015)]. Available online: http://www.usrds.org/2014/view/
    1. Sociedad Española de Nefrología (S.E.N.) Informe de 2013 (Congreso de Barcelona, 2014) [(accessed on 6 June 2015)]. Available online: http://www.senefro.org/modules.php?name=webstructure&idwebstructure=128.
    1. Healthypeople.gov. 2020 Topics & Objectives. Chronic Kidney Disease. [(accessed on 6 June 2015)]; Available online: http://www.healthypeople.gov/2020/
    1. Williams M.E., Lacson E., Teng M., Ofsthum N., Lazarus J.M. Hemodialyzed type I and type II diabetic patients in the US: Characteristics, glycemic control and survival. Kidney Int. 2006;70:1503–1509. doi: 10.1038/sj.ki.5001789. - DOI - PubMed
    1. Wolfe R.A., Ashby V.B., Milford E.L., Ojo A.O., Ettenger R.E., Agodoa L.Y., Held P.J., Port F.K. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation and recipients of first cadaveric transplant. N. Engl. J. Med. 1999;341:1725–1730. doi: 10.1056/NEJM199912023412303. - DOI - PubMed

LinkOut - more resources